Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
2,089.00
-91.10 (-4.18%)
At close: Mar 23, 2026

Glenmark Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
589,517434,866270,463131,124124,718131,124
Market Cap Growth
63.34%60.79%106.27%5.14%-4.88%125.75%
Enterprise Value
574,855434,470315,126164,781152,778150,427
Last Close Price
2089.001537.28954.74461.55436.18456.42
PE Ratio
55.3541.53-44.1113.2413.52
Forward PE
25.5226.0226.4510.1010.5912.50
PS Ratio
3.573.252.141.131.011.20
PB Ratio
6.154.913.451.331.321.86
P/TBV Ratio
7.595.894.151.861.832.77
P/FCF Ratio
---743.8039.1536.78
P/OCF Ratio
---20.9711.2511.59
PEG Ratio
1.091.251.120.631.711.14
EV/Sales Ratio
3.483.252.491.411.241.38
EV/EBITDA Ratio
13.9220.0417.2211.537.997.74
EV/EBIT Ratio
14.8922.7821.8014.488.308.77
EV/FCF Ratio
---934.7147.9642.20
Debt / Equity Ratio
0.130.280.160.470.420.71
Debt / EBITDA Ratio
0.301.090.643.031.982.45
Debt / FCF Ratio
---261.3812.4413.99
Net Debt / Equity Ratio
-0.150.09-0.050.350.270.54
Net Debt / EBITDA Ratio
-0.360.37-0.242.411.331.97
Net Debt / FCF Ratio
--0.500.37195.117.9910.77
Asset Turnover
-0.880.750.640.750.72
Inventory Turnover
-1.631.871.811.901.74
Quick Ratio
-0.940.751.061.081.00
Current Ratio
-1.561.282.101.771.75
Return on Equity (ROE)
-12.54%-20.70%-0.93%12.04%14.77%
Return on Assets (ROA)
-7.84%5.36%3.90%7.04%7.08%
Return on Invested Capital (ROIC)
31.57%16.74%-700.97%-3.36%11.09%11.45%
Return on Capital Employed (ROCE)
-18.90%16.90%8.00%14.80%15.00%
Earnings Yield
1.81%2.41%-5.55%2.27%7.55%7.40%
FCF Yield
--3.63%-4.30%0.13%2.55%2.72%
Dividend Yield
0.23%0.16%0.26%0.54%0.57%0.55%
Payout Ratio
-6.73%-23.68%9.84%7.26%
Buyback Yield / Dilution
-0.04%-0.01%-0.00%---
Total Shareholder Return
0.19%0.15%0.26%0.54%0.57%0.55%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.